David Farr

In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action

Cliff H. Battram, Steven J. Charlton, Bernard Cuenoud et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 162 citations

Medicine, Medicinal Chemistry, Pharmacology +12

The Identification of Indacaterol as an Ultralong-Acting Inhaled β₂-Adrenoceptor Agonist

François Baur, David T. Beattie, David Beer et al. · Journal of Medicinal Chemistry · 2010 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol

David T. Beattie, David Beer, Michelle Bradley et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters

David A. Sandham, Lucy Barker, David T. Beattie et al. · Bioorganic & Medicinal Chemistry · 2004 · 22 citations

Pharmacy, Chemistry, Medicinal Chemistry +8

Potent and selective xanthine-based inhibitors of phosphodiesterase 5

Nichola J. Arnold, Ruth Arnold, David Beer et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11